BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33433358)

  • 21. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.
    Guan H; Shang G; Cui Y; Liu J; Sun X; Cao W; Wang Y; Li Y
    J Cell Physiol; 2019 Jun; 234(6):8998-9007. PubMed ID: 30317613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S; Li W; Guo A
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
    Han Z; Shi L
    Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis.
    Cui H; Zhao J
    J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA HULC induces the progression of osteosarcoma by regulating the miR-372-3p/HMGB1 signalling axis.
    Li Y; Liu JJ; Zhou JH; Chen R; Cen CQ
    Mol Med; 2020 Mar; 26(1):26. PubMed ID: 32188407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p].
    Yang H; Cao C; Wang LJ
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449
    [No Abstract]   [Full Text] [Related]  

  • 28. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
    Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
    Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression.
    Sun L; Yang C; Xu J; Feng Y; Wang L; Cui T
    DNA Cell Biol; 2016 Dec; 35(12):812-818. PubMed ID: 27860482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide analyses of XRN1-sensitive targets in osteosarcoma cells identify disease-relevant transcripts containing G-rich motifs.
    Pashler AL; Towler BP; Jones CI; Haime HJ; Burgess T; Newbury SF
    RNA; 2021 Oct; 27(10):1265-1280. PubMed ID: 34266995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis.
    Zhou B; Li L; Li Y; Sun H; Zeng C
    Biomed Pharmacother; 2018 Oct; 106():850-857. PubMed ID: 30119255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma.
    Polvani S; Martignano F; Scoccianti G; Pasqui A; Palomba AR; Conticello S; Galli A; Palchetti I; Caporalini C; Antonuzzo L; Campanacci DA; Pillozzi S
    Anticancer Drugs; 2022 Mar; 33(3):278-285. PubMed ID: 35045526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma.
    Li Y; Zhang T; Zhang Y; Zhao X; Wang W
    Cancer Sci; 2018 Oct; 109(10):3093-3104. PubMed ID: 30099814
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 35. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H; Zhao L
    J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma.
    Rothzerg E; Ho XD; Xu J; Wood D; Märtson A; Kõks S
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1.
    Zhang YX; Cui HX; Liu L; Yi GK
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6045-6052. PubMed ID: 31364121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression assessment of a panel of long non-coding RNAs in gastric malignancy.
    Esfandi F; Salehnezhad T; Taheri M; Afsharpad M; Hafez AA; Oskooei VK; Ghafouri-Fard S
    Exp Mol Pathol; 2020 Apr; 113():104383. PubMed ID: 31982396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression.
    He JW; Li DJ; Zhou JH; Zhu YL; Yu BQ
    Biochem Biophys Res Commun; 2020 Jun; 526(3):670-677. PubMed ID: 32248969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA
    Li S; Liu F; Pei Y; Wang W; Zheng K; Zhang X
    Aging (Albany NY); 2019 Sep; 11(18):7678-7693. PubMed ID: 31525734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.